Short answer
Core Laboratories Inc. /DE/ (CLB) filed an 8-K current report with the SEC on April 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 financial results announced on April 29, 2026.
Core Laboratories Inc. /DE/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results announced on April 29, 2026
- Investor focus shifts to the accompanying press release for revenue, profitability, cash flow, and guidance details
Item 7.01 · Regulation FD Disclosure
- Quarterly cash dividend of $0.01 per share announced
- Shareholder record date May 11, 2026
- Payment date June 1, 2026
- Dividend signals continued shareholder distributions, with cash impact dependent on shares outstanding
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $121.8M, down 12% sequentially, while adjusted operating income $6.6M fell 58%
- Middle East conflict, weather disruptions, and delayed shipments materially pressured both segments
- GAAP loss per share $0.02; adjusted EPS $0.06 versus $0.21 in Q4
- Free cash flow $0.5M, net debt increased $3.9M to $94.2M, leverage ratio 1.20
- Q2 guidance implies modest recovery: revenue $123M-$131M, adjusted EPS $0.06-$0.12, dividend $0.01 per share
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Core Laboratories Inc. /DE/ 8-K filings
Get the next CLB 8-K as it lands
Follow CLB for push alerts, or ask the research agent what this filing means.